Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.79% |
| 2 | Consumer Discretionary | 0.82% |
| 3 | Financials | 0.79% |
| 4 | Healthcare | 0.66% |
| 5 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11626
Waldencast
WALD
$176M
| $128K | ﹤0.01% |
52,148
+21,572
| +71% | +$54.6K |
|
|
ADVM
11627
DELISTED
Adverum Biotechnologies
ADVM
| $127K | ﹤0.01% |
59,211
+21,877
| +59% | +$61.2K |
|
11628
Wrap Technologies
WRAP
$95.1M
| $127K | ﹤0.01% |
81,557
+29,082
| +55% | +$43.8K |
|
11629
Hooker Furnishings Corp
HOFT
$148M
| $127K | ﹤0.01% |
12,011
-8,002
| -40% | -$77.3K |
|
11630
CALL
AngioDynamics
ANGO
$649M
| $127K | ﹤0.01% |
+12,800
| New | +$125K |
|
|
PLL
11631
CALL
DELISTED
Piedmont Lithium
PLL
| $127K | ﹤0.01% |
21,800
-50,100
| -70% | -$327K |
|
|
BRFS
11632
DELISTED
BRF SA
BRFS
| $127K | ﹤0.01% |
34,725
+11,782
| +51% | +$42.6K |
|
|
FDSB
11633
Fifth District Bancorp
FDSB
$95.6M
| $127K | ﹤0.01% |
+10,255
| New | +$125K |
|
11634
CALL
MicroCloud Hologram
HOLO
$41.9M
| $126K | ﹤0.01% |
25,900
+22,977
| +786% | +$239K |
|
|
GRX
11635
Gabelli Healthcare & Wellness Trust
GRX
$149M
| $126K | ﹤0.01% |
+13,360
| New | +$127K |
|
11636
Nuveen Massachusetts Quality Municipal Income Fund
NMT
$129M
| $126K | ﹤0.01% |
+10,710
| New | +$126K |
|
11637
PUT
Arteris
AIP
$1.12B
| $126K | ﹤0.01% |
+13,200
| New | +$97.3K |
|
11638
Pyxis Oncology
PYXS
$279M
| $126K | ﹤0.01% |
114,359
+49,471
| +76% | +$55.7K |
|
11639
Teucrium Sugar Fund
CANE
$54.7M
| $126K | ﹤0.01% |
11,480
-33,642
| -75% | -$386K |
|
11640
PUT
ProFrac Holding
ACDC
$841M
| $126K | ﹤0.01% |
16,200
-400
| -2% | -$2.62K |
|
11641
CALL
Greystone Housing Impact Investors LP
GHI
$152M
| $126K | ﹤0.01% |
11,100
+500
| +5% | +$5.86K |
|
11642
Quadratic Deflation ETF
BNDD
$18M
| $126K | ﹤0.01% |
1,255
-2,020
| -62% | -$204K |
|
|
EFT
11643
Eaton Vance Floating-Rate Income Trust
EFT
$283M
| $126K | ﹤0.01% |
+10,063
| New | +$122K |
|
11644
Energy Vault
NRGV
$673M
| $125K | ﹤0.01% |
174,877
+6,733
| +4% | +$5.44K |
|
11645
Inseego
INSG
$74.2M
| $125K | ﹤0.01% |
15,204
-165,704
| -92% | -$1.3M |
|
11646
PUT
MiMedx Group
MDXG
$644M
| $125K | ﹤0.01% |
20,500
-6,600
| -24% | -$43.9K |
|
11647
T-Rex 2X Inverse NVIDIA Daily Target ETF
NVDQ
$20.9M
| $125K | ﹤0.01% |
4,578
-30,754
| -87% | -$1.52M |
|
|
NINE
11648
DELISTED
Nine Energy Service
NINE
| $124K | ﹤0.01% |
161,292
+85,334
| +112% | +$62.6K |
|
11649
Inter&Co
INTR
$2.44B
| $124K | ﹤0.01% |
16,727
-29,700
| -64% | -$197K |
|
11650
Zura Bio
ZURA
$574M
| $124K | ﹤0.01% |
118,228
+53,186
| +82% | +$63.6K |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2025 filing shows 1,720 new, 5,716 increased, 5,055 reduced and 1,538 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.